Literature DB >> 28741042

The first case of lymphogranuloma venereum in a woman in East-Central Europe and its multiple co-infections.

Katerina Juzlova1, Filip Rob2, Hana Zakoucka3, Andrea Kubatova2, Zuzana Secnikova2, Martina Krasova2, Petr Bohac2, Jana Hercogova2.   

Abstract

We are reporting the first case of lymphogranuloma venereum in women in East-Central Europe. A 22-year-old heterosexual woman attended our department of venereology. She complained about a burning sensation in the urethra and vaginal discharge. Many tests were performed, and lymphogranuloma venereum, syphilis, gonorrhea, chlamydial urethritis and cervicitis, genital herpes, genital warts, and hepatitis C were diagnosed. Lymphogranuloma venereum was originally endemic in tropical and subtropical areas, but since 2003, outbreaks of this infection have been reported in North America, Europe, and Australia in men who have sex with men (MSM) community. To date, all cases of lymphogranuloma venereum in the Czech Republic appeared in men, predominantly in HIV-positive MSM. There are not many evidences about lymphogranuloma venereum (LGV) in women in developed countries. This report underlines the need for awareness of lymphogranuloma venereum in women among gynecologists, venereologists, and other physicians not only in Western Europe, but across all European countries.

Entities:  

Mesh:

Year:  2017        PMID: 28741042     DOI: 10.1007/s12223-017-0538-3

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  11 in total

1.  First case of Chlamydia trachomatis L2b proctitis in a woman.

Authors:  O Peuchant; C Baldit; C Le Roy; S Trombert-Paolantoni; M Clerc; C Bébéar; B de Barbeyrac
Journal:  Clin Microbiol Infect       Date:  2011-09-26       Impact factor: 8.067

2.  The laboratory diagnosis of herpes simplex virus infections.

Authors:  Ameeta Singh; Jutta Preiksaitis; Alex Ferenczy; Barbara Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

3.  The first case record of a female patient with bubonic lymphogranuloma venereum (LGV), serovariant L2b.

Authors:  Stephan P Verweij; Sander Ouburg; Harry de Vries; Servaas A Morré; Cees J W van Ginkel; Hanna Bos; Fré W Sebens
Journal:  Sex Transm Infect       Date:  2012-02-22       Impact factor: 3.519

4.  First detection of Chlamydia trachomatis LGV biovar in the Czech Republic, 2010-2011.

Authors:  D Vanousova; H Zakoucka; D Jilich; H Rozsypal; M Stankova; S Zufanova; N Vojackova; J Hercogova; J Marvan; L Machala
Journal:  Euro Surveill       Date:  2012-01-12

5.  Steady increase of lymphogranuloma venereum cases, Czech Republic, 2010 to 2015.

Authors:  Filip Rob; Kateřina Jůzlová; Helena Krutáková; Hana Zákoucká; Daniela Vaňousová; Zuzana Kružicová; Ladislav Machala; Dan Veselý; David Jilich; Jana Hercogová
Journal:  Euro Surveill       Date:  2016

6.  2013 European Guideline on the management of proctitis, proctocolitis and enteritis caused by sexually transmissible pathogens.

Authors:  Henry J C de Vries; Adele Zingoni; John A White; Jonathan D C Ross; Alexander Kreuter
Journal:  Int J STD AIDS       Date:  2013-12-18       Impact factor: 1.359

7.  Lymphogranuloma venereum in Europe, 2003-2008.

Authors:  E J Savage; M J van de Laar; A Gallay; M van der Sande; O Hamouda; A Sasse; S Hoffmann; M Diez; M J Borrego; C M Lowndes; C Ison
Journal:  Euro Surveill       Date:  2009-12-03

Review 8.  Current trend on syphilis diagnosis: issues and challenges.

Authors:  Muhammad G Morshed
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 9.  Lymphogranuloma venereum: diagnostic and treatment challenges.

Authors:  Romana Ceovic; Sandra Jerkovic Gulin
Journal:  Infect Drug Resist       Date:  2015-03-27       Impact factor: 4.003

10.  Asymptomatic Lymphogranuloma Venereum in Men who Have Sex with Men, United Kingdom.

Authors:  Cara Saxon; Gwenda Hughes; Catherine Ison
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.